Tandem Diabetes Care (TNDM) Other Non-Current Assets (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Other Non-Current Assets for 14 consecutive years, with $32.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets rose 88.02% year-over-year to $32.6 million; the trailing twelve-month figure through Jun 2026 stood at $32.6 million (up 88.02% YoY), and the FY2025 full-year result was $22.9 million, up 342.62% from the prior year.
• Other Non-Current Assets improved to $32.6 million in Q2 2026 per TNDM's latest filing, from $30.8 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $40.3 million in Q4 2023 and bottomed at $5.2 million in Q4 2024.
• Historically, Other Non-Current Assets has averaged $23.2 million across 5 years, with a median of $20.2 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets sank 87.19% in 2024, then jumped 342.62% in 2025.
• Over 5 years, Other Non-Current Assets stood at $23.6 million in 2022, then soared by 70.69% to $40.3 million in 2023, then tumbled by 87.19% to $5.2 million in 2024, then surged by 342.62% to $22.9 million in 2025, then jumped by 42.6% to $32.6 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $32.6 million, $30.8 million, and $22.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.